Ultrasound-Guided Versus Standard Margin Selection in Ileocecal Resection of Terminal Ileal CD
NCT07680283 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2026-08-27
Summary
This is a Phase II, single-center (Cleveland Clinic), two-arm, randomized, parallel-group superiority trial. The two arms will compare IOUS-guided margin selection against standard macroscopic margin selection in patients undergoing ileocolic resection for terminal ileal Crohn's disease. Patients and outcome assessors (pathologists, endoscopists) will be blinded to the intervention arm, while surgeons, by the nature of the intervention, cannot be blinded. Randomization will be computer-generated with concealed allocation using permuted blocks to ensure balanced group sizes.
Conditions
- Crohn's Disease (CD)
Interventions
- DEVICE
-
IOUS-guided margin selection
Intra-operative ultrasound (IOUS)-guided proximal resection margin selection during ileocolic resection for terminal ileal Crohn's disease
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-30
- Primary Completion
- 2028-08-31
- Completion
- 2029-01-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Minimally Invasive Surgery in Crohn's Disease: Laparoscopic vs Robotic
NCT05161442 ·Status: COMPLETED
-
Reliability of IUS in Crohn's Disease
NCT06833450 ·Status: RECRUITING ·Phase: NA
-
Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures
NCT06203782 ·Status: RECRUITING ·Phase: NA
-
Mesenteric Surgical Margin for Crohn's Disease Endoscopic Recurrence
NCT06241170 ·Status: RECRUITING ·Phase: NA
-
Combination CurQD and Vedolizumab in Ulcerative Colitis
NCT07665294 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Prediction and Close Monitoring of Postoperative Recurrence by Intestinal Ultrasound After Ileocecal Resection in Crohn's Disease Patients
NCT05713409 ·Status: UNKNOWN
-
Validation of an IUS Activity Index
NCT05407350 ·Status: UNKNOWN
-
Early Bowel Resection for Terminal Ileal Crohn's Disease
NCT06116604 ·Status: RECRUITING
-
The IUSS Crohn's Study: A Feasibility Study
NCT03939117 ·Status: COMPLETED
-
Ultrasound Evaluation of Crohn's Disease
NCT03235180 ·Status: TERMINATED ·Phase: PHASE4
-
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
NCT06882993 ·Status: RECRUITING ·Phase: NA
-
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease
NCT01183403 ·Status: COMPLETED
-
Laparoscopy Combined With Enhanced Recovery Pathway
NCT02777034 ·Status: UNKNOWN ·Phase: NA
-
Extended Mesenteric Resection in Ileocecal Crohn's Disease.
NCT06324838 ·Status: RECRUITING ·Phase: NA
-
Regenerative Endoscopy in Refractory Perianal Crohn's Disease
NCT07652632 ·Status: RECRUITING ·Phase: NA
-
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
NCT07694674 ·Status: RECRUITING
-
Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT Study
NCT06534216 ·Status: ACTIVE_NOT_RECRUITING
-
Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis
NCT03863886 ·Status: UNKNOWN ·Phase: NA
-
Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up
NCT03487900 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Biologic Signatures in Crohn's Patients Undergoing Surgery
NCT06146335 ·Status: COMPLETED ·Phase: NA
-
The Utility of Hand-held Ultrasound Devices to Detect Bowel Wall Inflammatory Activity in Crohn's Disease
NCT06686589 ·Status: NOT_YET_RECRUITING
-
Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
NCT06299631 ·Status: COMPLETED
-
Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease
NCT02913508 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection
NCT02872506 ·Status: WITHDRAWN ·Phase: NA
-
A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease
NCT02367183 ·Status: COMPLETED ·Phase: PHASE1